Kymera Therapeutics, Inc. (KYMR)
NASDAQ: KYMR · Real-Time Price · USD
43.96
-0.09 (-0.20%)
Nov 21, 2024, 3:54 PM EST - Market open
Kymera Therapeutics Stock Forecast
Stock Price Forecast
The 14 analysts with 12-month price forecasts for Kymera Therapeutics stock have an average target of 52.14, with a low estimate of 30 and a high estimate of 74. The average target predicts an increase of 18.61% from the current stock price of 43.96.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for KYMR stock from 14 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 | 4 |
Buy | 3 | 3 | 4 | 5 | 5 | 6 |
Hold | 5 | 6 | 4 | 4 | 4 | 4 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 11 | 12 | 11 | 12 | 12 | 14 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stephens & Co. | Stephens & Co. | Buy Initiates $65 | Buy | Initiates | $65 | +47.86% | Nov 18, 2024 |
Morgan Stanley | Morgan Stanley | Hold Maintains $45 → $49 | Hold | Maintains | $45 → $49 | +11.46% | Nov 6, 2024 |
UBS | UBS | Strong Buy Maintains $80 → $74 | Strong Buy | Maintains | $80 → $74 | +68.33% | Nov 4, 2024 |
Truist Securities | Truist Securities | Strong Buy Reiterates $54 → $53 | Strong Buy | Reiterates | $54 → $53 | +20.56% | Nov 1, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $52 → $56 | Buy | Maintains | $52 → $56 | +27.39% | Sep 27, 2024 |
Financial Forecast
Revenue This Year
52.64M
from 78.59M
Decreased by -33.02%
Revenue Next Year
63.94M
from 52.64M
Increased by 21.47%
EPS This Year
-2.90
from -2.52
EPS Next Year
-3.20
from -2.90
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 78.8M | 153.6M | 157.3M | ||
Avg | 52.6M | 63.9M | 47.8M | ||
Low | 41.2M | 14.7M | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 0.2% | 191.7% | 146.0% | ||
Avg | -33.0% | 21.5% | -25.2% | ||
Low | -47.6% | -72.1% | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -2.24 | -1.80 | -2.70 | ||
Avg | -2.90 | -3.20 | -3.65 | ||
Low | -3.06 | -4.27 | -6.05 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.